Premenstrual disorders: Bridging research and clinical reality

Archives of Women's Mental Health

Volumn 6, Issue 4, 2003, Pages 287-292

  Yonkers, K A ^a,c   Pearlstein, T ^b   Rosenheck, R A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

Comorbidity; Premenstrual syndrome; Suicidal ideation

Indexed keywords

PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BEHAVIOR; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MOOD; PATIENT ATTITUDE; PATIENT SELECTION; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCREENING; SELF EVALUATION; SUICIDAL BEHAVIOR; TREATMENT OUTCOME; UNITED STATES;

ADULT; CONNECTICUT; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; PREMENSTRUAL SYNDROME; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SELF ASSESSMENT (PSYCHOLOGY); SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0345307639     PISSN: 14341816     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00737-003-0026-4     Document Type: Article

References (35)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders-DSM-IV. American Psychiatric Association, Washington, D.C.
2. Borenstein J, Dean B, Endicott J, Wong J, Brown C, Dickerson V, Yonkers K (2003) The economic impact of premenstrual syndrome. J Reprod Med 48.
3. Cohen L, Miner C, Brown E, Freeman E, Halbreich U, Sundell K, McCray S (2002) Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol 100(3): 435-444.
4. Endicott J, Harrison W (1993) Regarding Daily Record of Severity of Problems (DSRP). Available from Dr. Endicott, Columbia University.
5. Eriksson E, Hedberg MA, Andersch B, Sundblad C (1995) The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12(2): 169-176.
6. Freeman E, Rickels K, Sondheimer S, Polansky M (1999) Differential reponse to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch Gen Psychiatry 56(10): 932-939.
7. Freeman E, Rickels K, Sondheimer S, Polansky M (2001) Concurrent use of oral contraceptives with antidepressants for premenstrual syndromes. J Clin Psychopharmacol 21(5): 540-542.
8. Freeman EW, Sondheimer SJ, Polansky M, Garcia-Espagna B (2000) Predictors of response to sertraline treatment of severe premenstrual syndromes. J Clin Psychiatry 61(8): 579-584.
9. Graham CA, Sherwin BB (1992) A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 36: 257-266.
10. Halbreich U, Smoller JW (1997) Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 58: 1-4.
11. Halbreich U, Bergeron R, Yonkers K, Freeman E, Stout A, Cohen L (2002) Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstet Gynecol 100(6): 1219-1229.
12. Jermain DM, Preece CK, Sykes RL, Sulak PJ (1999) Luteal phase sertraline for premenstrual dysphoric disorder: Results of a double-blind, placebo-controlled, crossover study. Arch Fam Med 8(July/Aug): 328-332.
13. Landen M, Sorvik K, Ysander C, Allgulander C, Nissbrandt H, Gezelius B, Hunter B, Eriksson E (2002) A placebo-controlled trial exploring the efficacy of paroxetine for the treatment of premenstrual dysphoria. APA, Philadelphia.
14. Menkes DB, Taghavi E, Mason PA, Spears GFS, Howard RC (1992) Fluoxetine treatment of severe premenstrual syndrome. Br Med J 305: 346-347.
15. Miner C, Brown E, McCray S, Gonzales J, Wohlreich M (2002) Weekly luteal phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial, Clin Therapeut 24(3): 417-433.
16. Ozeren S, Corakci A, Yucesoy I, Mercan R, Erhan G (1997) Fluoxetine in the treatment of premenstrual syndrome. Eur J Obstet Gynecol Reprod Biol 73: 167-170.
17. Pearlstein TB, Stone AB, Lund SA, Scheft H, Zlotnick C, Brown WA (1997) Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol 17(4): 261-265.
18. Plouffe L, Stewart K, Craft KS, Maddox MS, Rausch JL (1993) Diagnostic and treatment results from a southeastern academic center-based premenstrual syndrome clinic: The first year. Am J Obstet Gynecol 169: 295-307.
19. Rubinow DR, Roy-Byrne P, Hoban MC, Gold PW, Post RM (1984) Prospective assessment of menstrually related mood disorders. Am J Psychiatry 141(5): 684-686.
20. Spitzer RL, Williams JBW, Kroenke K (1994) Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 Study. J Am Med Assoc 272: 1749-1756.
21. Spitzer R, Williams J, Kroenke K, Hornyak R, McMurray J (2000) Validity and utility of the Patient Health Questionnaire (PHQ) in assessing 3000 obstetric gynecology patients: the Prime-MD BHQ Obstetric Gynecology Study. Am J Obstet Gynecol 183(3): 759-769.
22. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D (1995) Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 332(23): 1529-1534.
23. Sternfeld B, Swindle R, Chawla A, Long S, Kennedy S (2002) Severity of premenstrual symptoms in a health maintenance organization population. Obstet Gynecol 99(6): 1014-1024.
24. Stone AB, Pearlstein TB, Brown WA (1991) Fluoxetine in the treatment of late luteat phase dysphoric disorder. J Clin Psychiatry 52(7): 290-293.
25. Su T-P, Schmidt PJ, Danaceau MA, Tobin MB, Rosenstein DL, Murphy DL, Rubinow DR (1997) Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology 16(5): 346-356.
26. Sundblad C, Modigh K, Andersch B, Eriksson E (1992) Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial. Acta Psychiatr Scand 85: 39-47.
27. Sundblad C, Hedberg MA, Eriksson E (1993) Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: A placebo-controlled trial. Neuropsychopharmacology 9(2): 133-145.
28. Thys-Jacobs S, Ceccarelli S, Bierman A, Weisman H, Cohen MA, Alvir J (1989) Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med 4(3): 183-189.
29. West C (1989) The characteristics of 100 women presenting to a gynecological clinic with premenstrual complaints. Acta Obstetr Gynecol Scand 68: 743-747.
30. Wikander I, Sunblad C, Andersch B, Dagnell I, Sylberstein D, Bengtsson F, Eriksson E (1998) Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phase more effective than continuous medication throughtout the menstrual cycle? J Clin Psychopharmacol 18(5): 390-398.
31. Wittchen H, Becker E, Lieb R, Krause P (2002) Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32(1): 119-132.
32. Wood SH, Mortola JF, Chan Y-F, Moossazadeh F, Yen SSC (1992) Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. J Am Coll Obstet Gynecol 80: 339-344.
33. Yonkers KA, Halbreich U, Freeman EW, Brown CS, Pearlstein TB (1996) Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull 32(1): 41-46.
34. Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W, Group TSPDCS (1997) Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. J Am Med Assoc 278(12): 983-988.
35. Young SA, Hurt PH, Benedek DM, Howard RS (1998) Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: A randomized, double-blind, placebo-controlled crossover trial. J Clin Psychiatry 59(2): 76-80.